FRATTA, WALTER
 Distribuzione geografica
Continente #
EU - Europa 220.608
NA - Nord America 19.469
AS - Asia 8.109
SA - Sud America 1.134
AF - Africa 177
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 18
Totale 249.539
Nazione #
IT - Italia 207.469
US - Stati Uniti d'America 19.206
NL - Olanda 8.008
CN - Cina 3.124
SG - Singapore 3.034
UA - Ucraina 1.489
SE - Svezia 1.057
BR - Brasile 915
DE - Germania 658
GB - Regno Unito 610
FI - Finlandia 595
VN - Vietnam 520
FR - Francia 401
IN - India 239
HK - Hong Kong 221
KR - Corea 204
BD - Bangladesh 148
CA - Canada 143
TR - Turchia 121
IQ - Iraq 77
RU - Federazione Russa 73
AR - Argentina 66
MX - Messico 55
JP - Giappone 51
PK - Pakistan 48
ES - Italia 45
SA - Arabia Saudita 42
ZA - Sudafrica 38
BE - Belgio 37
EC - Ecuador 37
PH - Filippine 37
CO - Colombia 31
UZ - Uzbekistan 30
PL - Polonia 29
ID - Indonesia 27
MA - Marocco 26
VE - Venezuela 25
MU - Mauritius 22
MY - Malesia 20
AU - Australia 19
AT - Austria 18
IE - Irlanda 18
CL - Cile 17
JM - Giamaica 17
JO - Giordania 17
EU - Europa 16
CZ - Repubblica Ceca 15
KE - Kenya 15
IR - Iran 14
LB - Libano 14
NP - Nepal 14
TH - Thailandia 13
AE - Emirati Arabi Uniti 12
EG - Egitto 12
IL - Israele 12
PY - Paraguay 12
AZ - Azerbaigian 11
BO - Bolivia 11
ET - Etiopia 11
KZ - Kazakistan 11
RS - Serbia 10
NG - Nigeria 9
PE - Perù 9
HU - Ungheria 8
PA - Panama 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
BG - Bulgaria 7
CR - Costa Rica 7
DZ - Algeria 7
SN - Senegal 7
UY - Uruguay 7
HR - Croazia 6
LT - Lituania 6
PT - Portogallo 6
GE - Georgia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
OM - Oman 5
RO - Romania 5
AL - Albania 4
BB - Barbados 4
CH - Svizzera 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HN - Honduras 4
KG - Kirghizistan 4
LV - Lettonia 4
SC - Seychelles 4
TW - Taiwan 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
KW - Kuwait 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MN - Mongolia 3
MT - Malta 3
PR - Porto Rico 3
Totale 249.486
Città #
Cagliari 202.402
Amsterdam 7.961
Uta 4.127
Fairfield 1.716
Ashburn 1.532
Singapore 1.525
Woodbridge 1.384
Chandler 1.362
San Jose 1.008
Ann Arbor 990
Houston 966
Boardman 860
Dallas 857
Jacksonville 805
Wilmington 721
Seattle 670
Cambridge 577
Nyköping 573
Beijing 504
Dearborn 500
Los Angeles 427
Hefei 345
Helsinki 335
Nanjing 293
Buffalo 277
Council Bluffs 232
Lauterbourg 230
The Dalles 208
Boston 204
Hong Kong 202
Seoul 192
New York 187
Shanghai 178
Santa Clara 170
Ho Chi Minh City 135
Hanoi 127
Milan 125
Shenyang 105
San Diego 98
Guangzhou 81
Hebei 80
Redwood City 78
Nanchang 75
São Paulo 75
Tianjin 68
Mountain View 65
Munich 62
Verona 60
Washington 60
Jiaxing 58
Changsha 54
Orem 54
London 53
Toronto 53
Chennai 52
Redondo Beach 51
Frankfurt am Main 50
Atlanta 47
Jinan 45
Rome 44
Sassari 44
Chicago 42
Tokyo 41
Pune 40
Orange 38
Dong Ket 37
Zhengzhou 37
Brooklyn 36
Brussels 35
Norwalk 35
San Francisco 34
Manchester 33
Santa Maria Coghínas 33
Columbus 32
Auburn Hills 30
Denver 28
Montreal 28
Ningbo 28
Kunming 27
Tashkent 27
Turku 27
Wuhan 27
Rio de Janeiro 26
Baghdad 25
Da Nang 25
Hangzhou 23
Kocaeli 23
Belo Horizonte 22
Istanbul 22
Madrid 22
Brasília 21
Dhaka 20
Paris 20
Stockholm 20
Warsaw 20
Curitiba 19
Haiphong 19
Johannesburg 19
Mumbai 19
Nuremberg 19
Totale 237.498
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.675
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.636
Cannabinoid self-administration in rats: sex differences and the influence of ovarian function 4.489
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.382
BEHAVIORAL EFFECTS OF ACUTE ADMINISTRATION OF THE PPAR-α AGONIST PALMITOYLETHANOLAMIDE IN RATS 3.372
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.358
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 3.345
Emotional profile of female rats showing binge eating behavior 3.261
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones. 3.234
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS ALPHA AGONISTS ANTIDEPRESSANT-LIKE EFFECT: BEHAVIORAL CHARACTERIZATION IN RATS 3.202
Sex differences in addictive disorders 3.182
Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats 3.172
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.095
Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation 3.036
Acute administration of palmitoylethanolamide: behavioural studies 2.980
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.971
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.963
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.900
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.880
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.850
Antidepressant-like effect of clofibrate: a synthetic PPAR-a agonist 2.771
New perspectives on the use of cannabis in the treatment of psychiatric disorders 2.722
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.600
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.598
Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings 2.516
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.513
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.480
Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex 2.432
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 2.399
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.389
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 2.385
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.355
Brain activity of anandamide: a rewarding bliss? 2.280
Role of opioid receptors in the reinstatement of opioid-seeking behavior: an overview 2.271
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 2.232
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.231
Methoxetamine affects brain processing involved in emotional response in rats 2.188
Analysis of opioid-seeking reinstatement in the rat 2.143
The GABA(B) receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats 2.100
Brain proteolysis of oxytocin "in vitro" and "in vivo" changes during aging in male rats 2.051
Biochemical and immunoistochemical evidence for the presence of motilin in pig cerebellum 2.018
Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo (3.2.1) octanes 1.980
Antidepressant-like effect of clofibrate: a synthetic PPAR-α agonist 1.900
Chronic Blockade of CB1 Receptors Reverses Startle Gating Deficits and Associated Neurochemical Alterations in Isolation Reared Rats. 1.896
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.883
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.799
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.767
Sex differences in the self-administration of cannabinoids and other drugs of abuse 1.745
CANNABINOID-INDUCED ALTERATION IN THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALLING PATHWAY IN MALE, FEMALE AND OVARIECTOMIZED RATS 1.731
THC exposure during adolescence increases cannabinoid and heroin intake in female rats more than in males 1.726
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.680
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats 1.664
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking 1.652
null 1.579
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.488
Effects of modulation of endocannabinoid system on fat intake under a limited-access protocol of binge eating in female rats 1.460
The endocannabinoid system and nondrug rewarding behaviours 1.458
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.451
Hippocampal theta activity is modulated by cannabinoid type1receptor in rats 1.416
Plasma alpha-melanocyte stimulating hormone during the menstrual cycle in women 1.416
Drug and cue induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones 1.402
Role of the endocannabinoid system in the central mechanisms regulating motivation for food 1.382
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.369
Dopamine-beta-hydroxylase inhibition potentiates cocaine effect on dopamine release in the medial prefrontal cortex 1.343
Neurobiological mechanisms of cannabinoid addiction 1.291
Cannabinoids and their therapeutic applications in mental disorders 1.274
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.254
Rimonabant reduces fat intake under a limited access protocol of binge eating disorder 1.231
Differential effects of THC-or CBD-rich cannabis extracts on working memory in rats 1.225
Oxytocin concentration changes in different rat brain areas but not in plasma during aging 1.202
Adolescent THC Exposition and vulnerability to Nicotine abuse 1.167
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 1.162
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 1.077
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 1.063
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 1.062
Cannabinoid-opioid interaction in relapse to drug-seeking 1.060
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 1.058
Cannabis: THC and beyond. Atto II 1.053
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition 1.034
Endocannabinoid system and opioid addiction: behavioural aspects 1.018
Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs 1.014
Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats 979
Nicotine consumption is regulated by a human polymorphism in dopamine neurons. 961
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 960
An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives 956
Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis 928
An altered thyroid status does not alter the met-enkephalin plasma concentration in humans 887
Molecular mechanisms of cannabinoid addiction 883
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2 873
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 866
Nicotinic α7 receptors as a new target for treatment of cannabis abuse 846
Failure of ketamine to interact with opiate receptors 829
Benzodiazepines induced voraciousness in cats and inhibition of amphetamine anorexia 825
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats. 801
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 777
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 774
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 765
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 752
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 740
null 738
Totale 191.229
Categoria #
all - tutte 346.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 346.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.727 0 0 0 0 0 0 0 0 0 0 0 1.727
2021/202211.216 1.328 895 443 946 1.277 879 632 526 911 1.123 1.192 1.064
2022/202316.589 1.473 1.885 2.030 1.361 1.378 1.732 812 1.557 1.244 1.029 1.387 701
2023/202417.453 980 628 892 1.421 1.709 3.019 2.257 1.072 967 1.362 1.542 1.604
2024/202538.600 8.349 8.379 4.996 3.519 1.751 1.981 2.739 362 596 4.672 618 638
2025/202617.200 1.074 698 1.983 1.189 1.002 1.012 2.245 555 4.671 1.433 963 375
Totale 250.068